Source: Annual Congress 2005 - Interstitial lung diseases and sarcoidosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Covic, T. Olariu, L. Florea, P. Gusbeth, N. Mardare, I. Caruntu, S. Stancu, L. Girneata, E. Mandache, G. Mircescu (Iasi, Bucharest, Romania). Lung involvement in ANCA associated crescentic glomerulonephritis. Eur Respir J 2005; 26: Suppl. 49, 320

Member's Comments

No comment yet.

Related content which might interest you: Prognosis of pulmonary fibrosis with usual interstitial pneumonia pattern in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-related nephritiss Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018 Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients Source: Breathe, 16 (1) 190321; 10.1183/20734735.0321-2019 Year: 2020 Interstitial lung disease with ANCA-associated vasculitis (AAV-ILD): Clinical features and survival compared to patients with ILD associated with systemic sclerosis and IPF Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Cure bronchiectasis associated with anti-neutrophil cytoplasmatic antibodies (ANCA) with immunosuppressive therapy Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 p-ANCA positive Hashimoto‘s thyroiditis with interstitial pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 83s Year: 2005 Differences between ANCA positive and negative lung fibrosis cases without vasculitis Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia Year: 2019 Antineutrophil cytoplasmic antibodies (ANCA) associated-bronchiectasis appears more severe than "idiopathic" bronchiectasis Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice Year: 2015 Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Cystic lesion in myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)- positive interstitial pneumonia: radiological and pathological anaylsis Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management Year: 2018 Clinical and pathological findings of patients with interstitial lung diseases associated with antisynthetase other than Jo-1 antibodies Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005 Diffuse alveolar hemorrhage and pulmonary fibrosis in MPO-ANCA-associated vasculitides Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005 Clinical features and CT findings of anti-Jo-1 antibody positive interstitial lung disease with or without polymyositis and dermatomyositis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Interstitial lung disease (ILD) in association with polymyositis-dermatomyositis (PM/DM) with predominant lymphocytic alveolitis and anti-Jo-1-antibodies Source: Eur Respir J 2002; 20: Suppl. 38, 586s Year: 2002 Silicosis, asbestosis and ANCA positivity Source: Eur Respir J 2001; 18: Suppl. 33, 437s Year: 2001 Autoantibodies to the surfactant protein D in patients with interstitial lung diseases associated with amyopathic dermatomyositis and systemic sclerosis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 Interstitial lung disease associated with ANCA positivity: a retrospective analysis Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Difference in chest HRCT findings in relation to ANCA subtypes in ANCA-associated vasculitis Source: International Congress 2019 – Granulomatous disorders: from bench to bedside Year: 2019 Clinical features of interstitial lung disease in polymyositis and dermatomyositis Source: Eur Respir J 2006; 28: Suppl. 50, 828s Year: 2006 Pulmonary vasculitis: update on the management of ANCA-associated vasculitis Source: Eur Respir Mon; 2009: 46: 251–264 Year: 2009 Nine cases of interstitial lung disease associated with anti-CADM140 antibody positive dermatomyositis Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012